Log in to save to my catalogue

Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therap...

Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therap...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_10a49dbcfd73422a921e6192fa595238

Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG‐MPN bioregistry

About this item

Full title

Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG‐MPN bioregistry

Publisher

United States: John Wiley and Sons Inc

Journal title

HemaSphere, 2025-03, Vol.9 (3), p.e70090-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley and Sons Inc

Subjects

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_10a49dbcfd73422a921e6192fa595238

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_10a49dbcfd73422a921e6192fa595238

Other Identifiers

ISSN

2572-9241

E-ISSN

2572-9241

DOI

10.1002/hem3.70090

How to access this item